TVM and Tillotts form company to take on ulcerative colitis
Mage Biologics aims to progress a novel, orally administered monoclonal antibody
Read More
Tag: tvm
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
